<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:tt="http://teletype.in/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>@artificialintelligence1</title><generator>teletype.in</generator><description><![CDATA[@artificialintelligence1]]></description><link>https://teletype.in/@artificialintelligence1?utm_source=teletype&amp;utm_medium=feed_rss&amp;utm_campaign=artificialintelligence1</link><atom:link rel="self" type="application/rss+xml" href="https://teletype.in/rss/artificialintelligence1?offset=0"></atom:link><atom:link rel="next" type="application/rss+xml" href="https://teletype.in/rss/artificialintelligence1?offset=10"></atom:link><atom:link rel="search" type="application/opensearchdescription+xml" title="Teletype" href="https://teletype.in/opensearch.xml"></atom:link><pubDate>Sun, 22 Nov 2026 18:15:36 GMT</pubDate><lastBuildDate>Sun, 22 Nov 2026 18:15:36 GMT</lastBuildDate><item><guid isPermaLink="true">https://teletype.in/@artificialintelligence1/fpyutRL5s</guid><link>https://teletype.in/@artificialintelligence1/fpyutRL5s?utm_source=teletype&amp;utm_medium=feed_rss&amp;utm_campaign=artificialintelligence1</link><comments>https://teletype.in/@artificialintelligence1/fpyutRL5s?utm_source=teletype&amp;utm_medium=feed_rss&amp;utm_campaign=artificialintelligence1#comments</comments><dc:creator>artificialintelligence1</dc:creator><title>Pharmacovigilance challenge with AI</title><pubDate>Thu, 15 Oct 2020 15:15:32 GMT</pubDate><media:content medium="image" url="https://teletype.in/files/eb/85/eb858e8e-2764-4331-9051-f94a57ccf551.png"></media:content><description><![CDATA[<img src="https://teletype.in/files/df/b5/dfb582d0-3065-4547-9d1f-c1e5044b9fe1.jpeg"></img>Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications.]]></description><content:encoded><![CDATA[
  <p>Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications.</p>
  <p><em><strong><a href="https://www.theinsightpartners.com/sample/TIPRE00003127/?utm_source=blog-10291" target="_blank">Download PDF Brochure of Study, Click Here!</a></strong></em></p>
  <figure class="m_original">
    <img src="https://teletype.in/files/df/b5/dfb582d0-3065-4547-9d1f-c1e5044b9fe1.jpeg" />
  </figure>
  <p>Artificial intelligence holds great promise to address key challenges and to provide new opportunities relevant to both aspects of Pharmacovigilance. The AI Solution for Pharmacovigilance enables advanced automation by leveraging artificial intelligence and machine learning.</p>
  <p>Using advanced analytics in the pharmacovigilance process will also aid better clustering of data and consequent discovery of associations, for instance, a selected patient group being more or less prone to developing an adverse event. In the long term, this also opens the opportunity to complement value-based reimbursement models with drug safety information.</p>
  <p><strong>Some activities involved in pharmacovigilance are:</strong></p>
  <p><strong>Coding of adverse events</strong></p>
  <p>Adverse event coding is the process by which information from an AE reporter, called the &quot;verbatim&quot;, is coded using standardized terminology from a medical coding dictionary, such as MedDRA (the most commonly used medical coding dictionary).</p>
  <p><strong>Expedited reporting</strong></p>
  <p>This refers to ICSRs (individual case safety reports) that involve a serious and unlisted event (an event not described in the drug&#x27;s labeling) that is considered related to the use of the drug (US FDA). (Spontaneous reports are typically considered to have a positive causality, whereas a clinical trial case will typically be assessed for causality by the clinical trial investigator and/or the license holder.)</p>
  <p><strong>Clinical trial reporting</strong></p>
  <p>Also known as AE (adverse event) or SAE (serious AE) reporting from clinical trials, safety information from clinical studies is used to establish a drug&#x27;s safety profile in humans and is a key component that drug regulatory authorities consider in the decision-making as to whether to grant or deny market authorization (market approval) for a drug. AE reporting occurs when study patients (subjects, participants) experience any kind of &quot;untoward&quot; event during the conducting of clinical trials.</p>
  <p><strong>Want to know more about Pharmacovigilance challenge with AI..?</strong></p>
  <h3><strong><em><a href="https://www.theinsightpartners.com/sample/TIPRE00003127/?utm_source=blog-10291" target="_blank">Get full information and PDF sample of Pharmacovigilance challenge with AI</a></em></strong></h3>

]]></content:encoded></item><item><guid isPermaLink="true">https://teletype.in/@artificialintelligence1/HYbfDyyuk</guid><link>https://teletype.in/@artificialintelligence1/HYbfDyyuk?utm_source=teletype&amp;utm_medium=feed_rss&amp;utm_campaign=artificialintelligence1</link><comments>https://teletype.in/@artificialintelligence1/HYbfDyyuk?utm_source=teletype&amp;utm_medium=feed_rss&amp;utm_campaign=artificialintelligence1#comments</comments><dc:creator>artificialintelligence1</dc:creator><title>An innovative solution for management of respiratory conditions: Smart inhaler</title><pubDate>Fri, 22 May 2020 14:25:08 GMT</pubDate><media:content medium="image" url="https://teletype.in/files/2c/a1/2ca1394a-b041-4858-8286-89a2f1a27aab.png"></media:content><description><![CDATA[<img src="https://teletype.in/files/b9/7b/b97b08bd-9dfa-45f9-b329-fe37d947bec0.jpeg"></img>smart inhalers market, based on the product, was segmented as, nebulizers and inhalers. In 2018, the inhalers held the largest share of the market, by product. In addition, the segment is also anticipated to grow at a significant rate during the forecast period. Inhalers are widely used in respiratory disorders such as asthma and COPD. They are available in various forms such as manually-actuated pressurized metered-dose inhalers, breath-actuated pressurized metered-dose inhalers, dry powder inhalers, and mist inhalers. The use of the type of inhaler highly depends on the intensity of the respiratory disorder and the need for its diagnosis.]]></description><content:encoded><![CDATA[
  <p>smart inhalers market, based on the product, was segmented as, nebulizers and inhalers. In 2018, the inhalers held the largest share of the market, by product. In addition, the segment is also anticipated to grow at a significant rate during the forecast period. Inhalers are widely used in respiratory disorders such as asthma and COPD. They are available in various forms such as manually-actuated pressurized metered-dose inhalers, breath-actuated pressurized metered-dose inhalers, dry powder inhalers, and mist inhalers. The use of the type of inhaler highly depends on the intensity of the respiratory disorder and the need for its diagnosis.</p>
  <h3><strong><a href="https://www.theinsightpartners.com/sample/TIPRE00004568/?utm_source=10291" target="_blank">Download Sample Copy Of Smart Inhalers</a></strong> </h3>
  <figure class="m_original">
    <img src="https://teletype.in/files/b9/7b/b97b08bd-9dfa-45f9-b329-fe37d947bec0.jpeg" width="700" />
    <figcaption>image credit: Insightscare.com</figcaption>
  </figure>
  <p></p>
  <p>The cases of asthma and COPD has been increasing across the globe at a significant rate. During recent years, there has been a rise in the number of smokers as well as air pollution in developed as well as developing countries across the globe. As per estimates provided by the WHO, there are currently 235 million people suffering from asthma across the globe. As per the Centers for Disease Control and Prevention (CDC), the number of adults above 18 years of age currently having asthma is approximately 19 million in the United States, accounting for almost 7.7% of the total adult population. Whereas, the number of individuals below 18 years of age suffering from asthma is 6.2 million, accounting for 8.4% of the total children population. Also, as per the WHO estimates published during December 2016, there were 383 000 deaths due to asthma in 2015.</p>
  <p>There have been limited developments made in the smart inhalers market during recent years. However, growth strategies such as approvals, collaborations, and partnerships have been witnessed in the market of smart inhalers. For instance, during July, 2018 Adherium received FDA approval for its Hailie sensor, which can be used along with ProAir HFA, Ventolin HFA, and Flovent HFA asthma inhalers. Also, during August 2018, Novartis AG and Propeller Health entered into a collaboration for the development of custom add-on sensor for the Breezhaler inhaler, a device intended to be used for the treatment of COPD.</p>
  <p>Inhalers segment is expected to grow the market for<strong> <a href="https://www.theinsightpartners.com/sample/TIPRE00004568/?utm_source=10291" target="_blank">smart inhalers</a></strong> over the forecast period for product segment.The major players operating in the smart inhalers market include GlaxoSmithKline plc, Adherium Ltd., Vectura Group plc, Novartis AG, Findair Sp. z o. o., Cohero Health, Crux Product Design Ltd, Teva Pharmaceuticals, 3M, and Amiko Digital Health Limited.</p>

]]></content:encoded></item><item><guid isPermaLink="true">https://teletype.in/@artificialintelligence1/LVo3fjz1I</guid><link>https://teletype.in/@artificialintelligence1/LVo3fjz1I?utm_source=teletype&amp;utm_medium=feed_rss&amp;utm_campaign=artificialintelligence1</link><comments>https://teletype.in/@artificialintelligence1/LVo3fjz1I?utm_source=teletype&amp;utm_medium=feed_rss&amp;utm_campaign=artificialintelligence1#comments</comments><dc:creator>artificialintelligence1</dc:creator><title>How IoT can help fight COVID-19 battle</title><pubDate>Thu, 23 Apr 2020 06:24:10 GMT</pubDate><media:content medium="image" url="https://teletype.in/files/0c/41/0c418cc6-7c4c-45a6-bbd4-dff1856e77b9.png"></media:content><description><![CDATA[<img src="https://teletype.in/files/2f/a9/2fa9bf33-86cb-4ef0-88c4-45449d6e0727.png"></img>The IoT in Healthcare helps in delivery of healthcare facilities through improved communication, between patients and healthcare providers, via connected medical devices. IoT in Healthcare enable the stakeholders particularly, providers and patients, to enhance patient care, reduce costs related to healthcare, reduction in errors, improved patient experience, and improved patient outcomes along with better disease management.]]></description><content:encoded><![CDATA[
  <p>The IoT in Healthcare helps in delivery of healthcare facilities through improved communication, between patients and healthcare providers, via connected medical devices. IoT in Healthcare enable the stakeholders particularly, providers and patients, to enhance patient care, reduce costs related to healthcare, reduction in errors, improved patient experience, and improved patient outcomes along with better disease management.</p>
  <p>Get PDF Sample: <a href="https://www.theinsightpartners.com/sample/TIPTE100000180/?utm_source=blog/10291" target="_blank">https://bit.ly/2xFZ52N</a> </p>
  <figure class="m_original">
    <img src="https://teletype.in/files/2f/a9/2fa9bf33-86cb-4ef0-88c4-45449d6e0727.png" width="700" />
    <figcaption>Image credit:oneteam.us</figcaption>
  </figure>
  <p>Here are exciting IoT applications in healthcare that are revolutionizing this space:</p>
  <p><strong>1. IoT Application in Healthcare: <a href="https://www.theinsightpartners.com/sample/TIPHE100001289/?utm_source=blog/10291" target="_blank">Remote Patient Monitoring</a></strong></p>
  <p>With a rise in cases of chronic illnesses such as diabetes and hypertension, there has been a rise in awareness regarding ones health. Also, in recent days, there has been a significant rise in the number of individuals suffering from heart related disorders. These factors have led to increase in the importance of maintaining health among the population in the developed as well as the developing nations. The demand for various health monitoring devices for maintain track of health status has increased significantly in the recent years. </p>
  <p>Here are some devices that facilitate remote monitoring:</p>
  <p>·         <strong>Continuous Glucose Monitor (CGM)</strong></p>
  <p>·         <strong>Smart Insulin Pens</strong></p>
  <p>·         <strong>Ingestible Sensors</strong></p>
  <p><strong>3. IoT Application in Healthcare: <a href="https://www.theinsightpartners.com/sample/TIPHE100000846/?utm_source=blog/10291" target="_blank">Sleep Management Device</a></strong></p>
  <p>Obstructive sleep apnea (OSA) is a common disorder which is categorized by the repetitive, complete or partial closure of the upper airway while asleep, which helps in the fragmentation of sleep and oxygen desaturation. Sleep apnea leads to significant morbidities, such as impairment of daytime functioning, which also impacts the quality of life. Moreover, a recent indication from the controlled trials is the proof for oral appliance therapy, which is very useful in controlling OSA in up to 50.0% of patients, which includes some patients with severe forms of OSA.  This evidence is fit for the use of oral appliances for the short term, and emerging for long-term treatment of OSA.</p>
  <p><strong> 4. IoT Application in Healthcare: <a href="https://www.theinsightpartners.com/sample/TIPRE00004568/?utm_source=blog/10291" target="_blank">Chronic Disease Management</a></strong></p>
  <p>Here are some IoT innovations being used to manage chronic illness:</p>
  <p><strong>Smart Inhalers:</strong> <a href="https://www.theinsightpartners.com/sample/TIPRE00004568/?utm_source=10291" target="_blank"><strong>Click here for For Smart Inhalers</strong></a></p>
  <p>The cases of asthma and COPD has been increasing across the globe at a significant rate. During recent years, there has been a rise in the number of smokers as well as air pollution in developed as well as developing countries across the globe. As per estimates provided by the WHO, there are currently 235 million people suffering from asthma across the globe. As per the Centers for Disease Control and Prevention (CDC), the number of adults above 18 years of age currently having asthma is approximately 19 million in the United States, accounting for almost 7.7% of the total adult population. Whereas, the number of individuals below 18 years of age suffering from asthma is 6.2 million, accounting for 8.4% of the total children population.</p>
  <p>Source: theinsightpartners</p>

]]></content:encoded></item></channel></rss>